Name: Dr. Srinivas Nanduri Professor nanduri.niperhyd@gov.in +91 40 23074750 Extn- 2007 Google Scholar Citations

ADDRESS, ROOM NO,

Department of Chemical Sciences
Room. No. 15 & 16, NIPER Hyderabad
Balanagar, Hyderabad-500037, TS, INDIA

QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

1. PhD (Chemistry): Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (1991)
2. M.Sc (Chemistry): Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (1988)
3. B.Sc (Chemistry): Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (1986)

EXPERIENCE

1. Professor, Department of Chemical Sciences at NIPER Hyderabad (Dec 2019 – Present)
2. Dean, NIPER Hyderabad (March, 2020 to September, 2021)
3. Associate Professor, Department of Chemistry at Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (Aug 2019- Dec 2019)
4. Associate Professor, Department of Process Chemistry at NIPER Hyderabad (Sep 2013- July 2019)
5. Director, Medicinal Chemistry department at Albany Molecular Research (India), Hyderabad (June 2012- June 2013)
6. Research Director, Aurigene Discovery Technologies Ltd., Bangalore (Dec 2008- May 2012)
7. Chief Scientific Manager, Biocon BMS Research Centre, Bangalore (March 2008- Nov 2008)
8. Senior Director, Dr. Reddy’s Laboratories Ltd., Hyderabad, INDIA (Sep 1995- Feb 2008)
9. Lecturer, Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (Jan 1992 – Aug 1995)

COURSES HANDLING(PHD/M.PHARM)

1. PT-560 : Synthetic Aspects of Process Chemistry
2. PT-630 : Synthetic Bulk Drug Technology
3. LG-510 : General Laboratory Experience
4. MC-650: Stereochemistry and Drug Action
5. PT-710: Technologies for Green Chemistry
6. NP-720: Natural Product-Based Drugs and Lead Molecules

PHD STUDENTS/MASTERS STUDENTS

Guided more than 50 M.S. (Pharm) / M. Tech (Pharm) students.
PhD: 5 (Guide) completed
10 ongoing

AWARDS / HONOURS

-

RESEARCH AREAS/INTEREST

Drug Discovery & Development in the areas of

       a. Anti-microbial
       b. Anti-cancer
       c. Neurodegenerative disorders

Process Optimization and Green Chemistry.

Natural products, Isolation and Characterization, total synthesis and semi-synthesis.

SPONSORED PROJECTS

S.No	Title of the Project	Funding Organization	Role	Amount (In INR)	Status
1	Design, synthesis, and development of scalable route towards novel compounds based on the hybrid structure of Hymenialdisins and Paullones and a novel scaffold derived from Variolins	Ministry of Earth Sciences	Principal Investigator (PI)	45 Lakhs (2016-2019)	Completed
2	Synthesis and therapeutic evaluation of new LpxC inhibitors as potent anti- bacterial agents	DST-SERB	Principal Investigator (PI)	43 Lakhs (2017-2020)	Completed
3	Repurposing Oxiconazole: Alone and in combination with PUFA's as a broad spectrum antibacterial agents	DBT	Co-Principal Investigator (Co-PI)	40 Lakhs (2019-2022)	In Progress
4	Design, synthesis and biological evaluation of new GSK3β; inhibitors as promising therapeutic agents for treating Traumatic brain injury and consequent neuronal degenerative diseases	ICMR	Principal Investigator (PI)	50 Lakhs (2020-2023)	In Progress
5	Development of a scalable route for the manufacture of Prussian Blue insoluble of Pharmaceutical grade, an FDA approved decorporation drug	LSRB	Co-Principal Investigator (Co-PI)	49 Lakhs (2019-2022)	In Progress

PUBLICATIONS / BOOK CHAPTERS

57 in peer reviewed journals
Please Click here to see the full list.

PATENTS

54 filed (19 granted)
Please Click here to see the full list.

INVITED TALKS

More than 30

CONFERENCES / SEMINARS / WORKSHOPS ORGANIZED

S.No	Name of the Conference /Seminar / Workshop	Year	Role
1	NIPER - PHARMA INDUSTRY MEET (SYNERGY - 2018) The Role of Academia in Strengthening the Indian Pharma	23rd August, 2018	Convener
2	Workshop on Drug Discovery & Development; Concept, Clinic & Commercialization (D3C3): Module III	13th -14th April, 2018	Convener
3	Workshop on Drug Discovery & Development; Concept, Clinic & Commercialization (D3C3): Module II	9th - 10th March, 2018	Convener
4	Workshop on Drug Discovery & Development; Concept, Clinic & Commercialization (D3C3): Module I	16th - 17th February, 2018	Convener
5	NIPER - Pharma Industry Meet (Role of Academia in Strengthening of Indian Pharma)	24th March 2017	Convener
6	Conference on Drug Discovery & Development (Focus on Cancer & Diabetes)	16th & 17th March, 2017	Convener
7	Conference on Innovations in Pharmaceutical Technologies & Workshop on GLP/GMP compliance	24th& 25th January 2017	Convener
8	Conference on "Quality Management in Bulk Drug and Formulation Manufacturing"	12th& 13th Aug. 2016	Convener
9	One day workshop on "Emerging Trends In Pharmaceutical Sciences"	9th July 2016	Convener
10	Conference on Fostering Innovation in Pharmaceutical and IPR Management	21st -22nd March 2016	Convener
11	Conference on Drug Discovery & Development (Global Scenario – Indian perspective)	20th -21st November 2015	Convener
12	National Conference on Innovative Processes for Bulk Drugs (IPBD)	26th - 27th March 2015	Convener
13	International Conference on Drugs for the Future: Infectious Diseases (DFID)	27th -28th March 2014	Convener

ADDITIONAL RESPONSIBILITIES

1. Coordinator, National Center for R & D Bulk Drugs Development
2. Coordinator, Avishkaran, BioNEST Incubation Center at NIPER-Hyderabad
3. Dean, NIPER-Hyderabad (March 2020- Aug 2021)
4. Head of the Department, Department of Chemical Sciences, NIPER-Hyderabad (Aug 2020- Aug 2021)
5. Convener, NIPER-JEE 2020 (Medical Devices)
6. Head of the Department, Department of Process Chemistry, NIPER-Hyderabad (2014-2019)
7. Placement Officer, NIPER-Hyderabad (2013-2018)

ANY OTHER INFORMATION

Developed 4 research labs for the chemical synthesis